Quest Diagnostics Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $772.0M | $645.0M | $709.0M | $556.0M | $849.0M | $556.0M | $471.0M | $720.9M |
| Depreciation & Amortization | $270.0M | $249.0M | $304.0M | $314.0M | $283.0M | $287.0M | $281.0M | $254.0M |
| Depreciation | $196.0M | $177.0M | $223.0M | $220.0M | $204.0M | $207.0M | $214.0M | $214.7M |
| Amortization | $74.0M | $72.0M | $81.0M | $94.0M | $79.0M | $75.0M | $61.0M | $33.1M |
| Stock-Based Compensation | $79.0M | $69.0M | $52.0M | $51.0M | $28.0M | $50.0M | $72.0M | $53.9M |
| Net Cash from Operating Activities | $1.18B | $1.12B | $821.0M | $944.0M | $652.0M | $1.19B | $895.0M | $1.12B |
| Investing Activities | ||||||||
| Capital Expenditures | $252.0M | $293.0M | $263.0M | $308.0M | $231.0M | $182.0M | $161.0M | $205.4M |
| Business Acquisitions | $581.0M | $139.0M | $67.0M | $728.0M | $213.0M | $51.0M | $1.30B | $0 |
| Net Cash from Investing Activities | $-830.0M | $-127.0M | $-362.0M | $-1.03B | $328.0M | $-217.0M | $-1.24B | $-216.5M |
| Financing Activities | ||||||||
| Dividends Paid | $247.0M | $223.0M | $212.0M | $187.0M | $185.0M | $108.0M | $65.0M | $71.3M |
| Stock Repurchases | $465.0M | $590.0M | $224.0M | $132.0M | $1.04B | $200.0M | $935.0M | $750.0M |
| Net Cash from Financing Activities | $-592.0M | $-738.0M | $-518.0M | $86.0M | $-1.11B | $-822.0M | $64.0M | $-986.5M |
| Net Change in Cash | $-222.0M | $226.0M | $-59.0M | $5.0M | $-126.0M | $148.0M | $-284.0M | $-85.0M |
| Free Cash Flow | $923.0M | $823.0M | $558.0M | $636.0M | $421.0M | $1.01B | $734.0M | $912.6M |